MX390246B - Composicion prebiotica sinergica. - Google Patents
Composicion prebiotica sinergica.Info
- Publication number
- MX390246B MX390246B MX2017003293A MX2017003293A MX390246B MX 390246 B MX390246 B MX 390246B MX 2017003293 A MX2017003293 A MX 2017003293A MX 2017003293 A MX2017003293 A MX 2017003293A MX 390246 B MX390246 B MX 390246B
- Authority
- MX
- Mexico
- Prior art keywords
- prebiotic
- synergical
- present
- prebiotic composition
- compositions
- Prior art date
Links
- 235000013406 prebiotics Nutrition 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 abstract 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical compound [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Substances OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 abstract 2
- 229940107187 fructooligosaccharide Drugs 0.000 abstract 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 abstract 2
- 150000003271 galactooligosaccharides Chemical class 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 abstract 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 abstract 1
- 229920001202 Inulin Polymers 0.000 abstract 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 abstract 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 abstract 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 abstract 1
- 229940061720 alpha hydroxy acid Drugs 0.000 abstract 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 abstract 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000004140 cleaning Methods 0.000 abstract 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 1
- 229940029339 inulin Drugs 0.000 abstract 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 abstract 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 abstract 1
- 229960000511 lactulose Drugs 0.000 abstract 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000001630 malic acid Substances 0.000 abstract 1
- 235000011090 malic acid Nutrition 0.000 abstract 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 239000011975 tartaric acid Substances 0.000 abstract 1
- 235000002906 tartaric acid Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
Abstract
La presente invención se refiere a composiciones y formulaciones prebióticas que comprenden un a-hidroxiácido y sus sales, tales como ácido láctico, glicólico, cítrico, tartárico o málico y un agente prebiótico, tal como inulina, fructooligosacárido (FOS), lactulosa, galactooligosacárido (GOS), rafinosa, estaquiosa, isomaltooligosacárido, y xilooligosacárido. Las composiciones prebióticas de la presente invención proporcionan un efecto prebiótico sorprendentemente sinérgico y pueden administrarse de varias formas a un usuario, tales como por aplicación a un sustrato de limpieza prehumedecido o papel sanitario seco.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2014/058369 WO2016053308A1 (en) | 2014-09-30 | 2014-09-30 | Synergistic prebiotic composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017003293A MX2017003293A (es) | 2017-06-21 |
| MX390246B true MX390246B (es) | 2025-03-20 |
Family
ID=55631163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017003293A MX390246B (es) | 2014-09-30 | 2014-09-30 | Composicion prebiotica sinergica. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10441603B2 (es) |
| EP (1) | EP3200766B1 (es) |
| KR (1) | KR20170065540A (es) |
| CN (1) | CN107072941B (es) |
| AU (1) | AU2014407509B2 (es) |
| BR (1) | BR112017004630B1 (es) |
| CO (1) | CO2017003280A2 (es) |
| MX (1) | MX390246B (es) |
| WO (1) | WO2016053308A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2636621C1 (ru) * | 2016-08-08 | 2017-11-24 | Федеральное государственное бюджетное научное учреждение "Прикаспийский зональный научно-исследовательский ветеринарный институт" | Препарат-пребиотик для овец |
| EP4034253B1 (en) * | 2019-09-23 | 2026-01-21 | The Regents Of The University Of Michigan | Compositions for increasing the efficacy of immunotherapies and vaccines |
| US12575591B2 (en) | 2019-10-17 | 2026-03-17 | Wake Forest University Health Sciences | Compositions useful for dietary supplements |
| US20220233559A1 (en) * | 2021-01-27 | 2022-07-28 | Prenexus Health, Inc. | Xylooligosaccharide as a multifunctional prebiotic |
| WO2026078116A1 (en) * | 2024-10-09 | 2026-04-16 | Roquette Frères | Substances for use as a prebiotic or as a medicine |
| CN119326802B (zh) * | 2024-12-19 | 2025-05-30 | 江西益百润生物科技有限公司 | 联合益生菌和益生元的组合物及其制备方法和应用 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2738652C3 (de) | 1977-08-26 | 1981-02-19 | Seiken Kai Foundation Juridical Person, Tondabayashi, Osaka (Japan) | Lactobacillus-Präparat und seine Verwendung bei der Bekämpfung bakterieller Infektionen und Entzündungen |
| US6716435B1 (en) | 1997-04-18 | 2004-04-06 | Ganeden Biotech, Inc. | Absorbent product containing absorbent structure and Bacillus coagulans |
| US7144173B2 (en) * | 1998-11-09 | 2006-12-05 | The Procter & Gamble Company | Cleaning composition, pad, wipe, implement, and system and method of use thereof |
| US20030185811A1 (en) | 2001-02-06 | 2003-10-02 | Steve Teasdale | Herbal extract and preparation thereof |
| AU2003266285A1 (en) | 2002-08-16 | 2004-03-11 | Finzelberg Gmbh And Co. Kg | Medicament, food supplement, and fodder additive |
| EP1471070A1 (en) | 2003-04-22 | 2004-10-27 | Royal Schouten Group N.V. | Method for recovering a secondary plant metabolite |
| WO2005021575A2 (en) | 2003-08-29 | 2005-03-10 | Gregor Reid | Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties |
| US20050112239A1 (en) * | 2003-11-20 | 2005-05-26 | Rudin Richard E. | Instant yogurt food product |
| US7332179B2 (en) | 2003-12-12 | 2008-02-19 | Kimberly-Clark Worldwide, Inc. | Tissue products comprising a cleansing composition |
| RU2006140784A (ru) | 2004-04-20 | 2008-05-27 | Дзе Юниверсити Оф Чикаго (Us) | Терапевтическая система доставки, содержащая высокомолекулярное пэг-подобное соединение |
| US8110215B2 (en) | 2004-04-30 | 2012-02-07 | Kimberly-Clark Worldwide, Inc. | Personal care products and methods for inhibiting the adherence of flora to skin |
| EP1600062A1 (en) | 2004-05-25 | 2005-11-30 | Cognis IP Management GmbH | Oral and/or topical compositions comprising prebiotics and sterols |
| US7642395B2 (en) | 2004-12-28 | 2010-01-05 | Kimberly-Clark Worldwide, Inc. | Composition and wipe for reducing viscosity of viscoelastic bodily fluids |
| EP1736537A1 (en) | 2005-06-22 | 2006-12-27 | OrganoBalance GmbH | Methods and means for protecting the skin against pathogenic microorganisms |
| EP1937418B1 (en) | 2005-08-22 | 2018-07-25 | Quick-Med Technologies, Inc. | Method of attaching an antimicrobial cationic polyelectrolyte to the surface of substrate |
| US8444811B2 (en) * | 2005-12-15 | 2013-05-21 | Kimberly-Clark Worldwide, Inc. | Process for increasing the basis weight of sheet materials |
| BRPI0710692A2 (pt) | 2006-04-21 | 2011-08-23 | Cadbury Adams Usa Llc | composições de revestimentos, composições de confeitaria e goma de mascar e métodos |
| GB0724550D0 (en) | 2007-12-18 | 2008-01-30 | Univ Hull | Formulations |
| IT1392672B1 (it) * | 2009-01-12 | 2012-03-16 | Wyeth Consumer Healthcare S P A | Composizioni comprendenti componenti probiotici e prebiotici e sali minerali, con lactoferrina |
| WO2010123419A1 (en) | 2009-04-20 | 2010-10-28 | Sca Hygiene Products Ab | Packaged wipe or hygiene tissue |
| WO2011053854A1 (en) | 2009-10-30 | 2011-05-05 | Biogenic Innovations, Llc | Use of methylsulfonylmethane (msm) to modulate microbial activity |
| JP6006117B2 (ja) | 2009-11-12 | 2016-10-12 | ネステク ソシエテ アノニム | 腸内微生物叢バランス及び健康を促進するための栄養組成物 |
| US8703716B2 (en) | 2010-03-12 | 2014-04-22 | Dsm Ip Assets B.V. | Maternal sialic acid supplementation |
| US20120035277A1 (en) | 2010-08-04 | 2012-02-09 | Hero Nutritionals, LLC | Liquid-filled chewable supplement |
| US9011909B2 (en) * | 2010-09-03 | 2015-04-21 | Wisconsin Pharmacal Company, Llc | Prebiotic suppositories |
| US8552251B2 (en) | 2010-10-08 | 2013-10-08 | Kimberly-Clark Worldwide, Inc. | Article with health-benefit agent delivery system |
| US9259019B2 (en) | 2010-11-11 | 2016-02-16 | Mars, Incorporated | Bifidobacteriumstrain |
| US8916012B2 (en) | 2010-12-28 | 2014-12-23 | Kimberly-Clark Worldwide, Inc. | Method of making substrates comprising frothed benefit agents |
| US8506978B2 (en) | 2010-12-28 | 2013-08-13 | Kimberly-Clark Worldwide, Inc. | Bacteriostatic tissue product |
| JP2014506923A (ja) | 2011-03-01 | 2014-03-20 | クオラム イノベーションズ リミテッド ライアビリティ カンパニー | 病原性バイオフィルムと関連した状態を治療するための物質および方法 |
| GB2495491A (en) | 2011-05-23 | 2013-04-17 | Bio4 Ltd | Pre-biotic skin wipe |
| CN102370598A (zh) * | 2011-09-30 | 2012-03-14 | 天津市中科健新材料技术有限公司 | 一种用于湿巾的益生元香体整理液 |
| US20150020946A1 (en) * | 2012-02-29 | 2015-01-22 | Bridgestone Corporation | Tire |
| JP6010310B2 (ja) * | 2012-03-05 | 2016-10-19 | Ｋｙｂ株式会社 | ロータリダンパ |
| EP2656862A1 (en) | 2012-04-24 | 2013-10-30 | The Procter & Gamble Company | Substrate comprising one or more human milk oligosaccharides and disposable absorbent article comprising the substrate |
| US9243367B2 (en) | 2012-10-05 | 2016-01-26 | Kimberly-Clark Worldwide, Inc. | Soft creped tissue |
| CN102871921A (zh) * | 2012-10-15 | 2013-01-16 | 金红叶纸业集团有限公司 | 洗手剂组合物 |
| CN103768651A (zh) * | 2012-10-17 | 2014-05-07 | 天津市中科健新材料技术有限公司 | 一种应用于婴儿纸尿裤的益生元粉体 |
| CN103110665B (zh) * | 2013-01-24 | 2015-12-02 | 量子高科(中国)生物股份有限公司 | 一种维护生殖道微生态屏障的组合物及其应用 |
| US20150080826A1 (en) | 2013-08-28 | 2015-03-19 | The Procter & Gamble Company | Substrate comprising oligogalacturonides and disposable absorbent article comprising the substrate |
| US20150209468A1 (en) | 2014-01-24 | 2015-07-30 | The Procter & Gamble Company | Hygiene article containing microorganism |
| KR101814967B1 (ko) | 2014-09-30 | 2018-01-04 | 킴벌리-클라크 월드와이드, 인크. | 크레이프된 프리바이오틱 티슈 |
-
2014
- 2014-09-30 WO PCT/US2014/058369 patent/WO2016053308A1/en not_active Ceased
- 2014-09-30 EP EP14903199.9A patent/EP3200766B1/en active Active
- 2014-09-30 CN CN201480081930.2A patent/CN107072941B/zh active Active
- 2014-09-30 KR KR1020177009906A patent/KR20170065540A/ko not_active Ceased
- 2014-09-30 MX MX2017003293A patent/MX390246B/es unknown
- 2014-09-30 US US15/512,951 patent/US10441603B2/en active Active
- 2014-09-30 BR BR112017004630-0A patent/BR112017004630B1/pt active IP Right Grant
- 2014-09-30 AU AU2014407509A patent/AU2014407509B2/en active Active
-
2017
- 2017-04-04 CO CONC2017/0003280A patent/CO2017003280A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014407509A1 (en) | 2017-04-13 |
| MX2017003293A (es) | 2017-06-21 |
| US20170258823A1 (en) | 2017-09-14 |
| EP3200766A4 (en) | 2018-06-06 |
| CN107072941B (zh) | 2020-10-13 |
| BR112017004630B1 (pt) | 2023-04-11 |
| CO2017003280A2 (es) | 2017-07-11 |
| EP3200766A1 (en) | 2017-08-09 |
| US10441603B2 (en) | 2019-10-15 |
| WO2016053308A1 (en) | 2016-04-07 |
| AU2014407509B2 (en) | 2020-09-03 |
| CN107072941A (zh) | 2017-08-18 |
| EP3200766B1 (en) | 2019-07-03 |
| KR20170065540A (ko) | 2017-06-13 |
| BR112017004630A2 (pt) | 2018-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017003280A2 (es) | Composición prebiótica sinérgica que comprende un agente prebiótico y un alfa-hidroxiácido, y toallita húmeda prebiótica que comprende una composición prebiótica líquida | |
| BR112017019411A2 (pt) | método para produção e uso de composição de detergente em forma de um tablete efervescente | |
| PH12017501079A1 (en) | 1,3-thiazol-2-yl substituted benzamides | |
| MX2016006060A (es) | Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños. | |
| AR097901A1 (es) | Agente beneficioso con partículas de administración | |
| MX374710B (es) | Composicion para la limpieza del cabello | |
| MX2016006220A (es) | Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños nacidos por cesarea. | |
| TN2015000371A1 (en) | Substituted imidazopyridazines | |
| MX339413B (es) | Composiciones liquidas de limpieza y desinfeccion. | |
| PH12016501807A1 (en) | Novel compounds | |
| MX2017010923A (es) | Composiciones para usar en el mejoramiento de la consistencia o la frecuencia de las heces en infantes o niños pequeños. | |
| MX378653B (es) | Composicion limpiadora auto-espumante para enjuagar que contiene ivermectina. | |
| PL3046948T3 (pl) | Modyfikowane kwasy poliasparaginowe, ich wytwarzanie i ich zastosowanie jako dyspergatorów i środków zapobiegających powstawaniu osadów w kompozycjach środków do prania, zmywania i czyszczenia oraz w uzdatnianiu wody | |
| MX389674B (es) | Composiciones que comprenden tensioactivos y metodos de uso de las composiciones. | |
| MX2015008704A (es) | Limpiador de horno de dosis unitaria de tableta solida. | |
| MY185456A (en) | Skin cleanser composition | |
| MX2016000163A (es) | Pirazolpiridinas sustituidas. | |
| BR112015004813A8 (pt) | composição de sabão, método de desinfecção de uma superfície e utilizações de uma composição | |
| PH12016501814A1 (en) | Inhibitors of the wnt signalling pathways | |
| CL2018002897A1 (es) | Sistemas de formulación para glicolípidos antimicrobianos. | |
| GB2547153A (en) | Anti-adherent botanical compositions | |
| PE20170510A1 (es) | Composicion prebiotica sinergica | |
| MX365973B (es) | Barras de limpieza con taurina. | |
| WO2013117375A3 (de) | Zusammensetzung enthaltend hydroxyethylcellulose | |
| MX2015007158A (es) | Antitranspirante/desodorante. |